Answers are grounded in this paper and cite their sources.
Cancer vaccine development has been vigorously pursued for 40 years. Immunity to tumor antigens can be elicited by most vaccines tested, but their clinical efficacy remains modest. We argue that a concerted international effort is necessary to understand the human antitumor immune response and achieve clinically effective cancer vaccines.
No takes yet. Share an insight, caveat, or question.
Romero et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: